UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Real-world associations among patient-physician sex concordance, treatment practices, and cancer outcomes

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18511-e18511

2023

Volltextzugriff (PDF)

Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.76-76

2023

Volltextzugriff (PDF)

Real-world use of biologics and its association with outcomes in RAS wild-type (WT) left-sided metastatic colorectal cancer (mCRC) in Canada

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.56-56

2023

Volltextzugriff (PDF)

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

Journal of clinical oncology, 2022-11, Vol.40 (31), p.3613-3622

2022

Volltextzugriff (PDF)

The association between medical cannabis and prescription opioid medication use in patients with early-stage cancer: A population-based study

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.228-228

2022

Volltextzugriff (PDF)

Real-world treatment patterns and clinical outcomes in early stage non-small cell lung cancer (eNSCLC) in Canada

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20504-e20504

2022

Volltextzugriff (PDF)

The impact of population-based EGFR testing in metastatic non-small cell lung cancer in Alberta

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21139-e21139

2022

Volltextzugriff (PDF)

Trends and disparities in the treatment of older adults with colon cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18776-e18776

2022

Volltextzugriff (PDF)

CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.318-318

2022

Volltextzugriff (PDF)

Safety and feasibility of rhenium-186 nanoliposome ( 186 RNL) in recurrent glioma: The ReSPECT phase 1 trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2061-2061

2021

Volltextzugriff (PDF)

Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2074-2074

2016

Volltextzugriff (PDF)

Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2512-2512

2016

Volltextzugriff (PDF)

Radiographic patterns of progression in patients with EGFR-mutant NSCLC undergoing EGFR TKI therapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19108-e19108

2015

Volltextzugriff (PDF)

First-in-human investigation of the oral first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS2615-TPS2615

2015

Volltextzugriff (PDF)

Perioperative DD-MVAC as a safe and efficacious treatment for MIBC: Results of a retrospective community center study with clinical correlates of toxicity and response

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15540-e15540

2015

Volltextzugriff (PDF)

BRAF V600 mutant colorectal cancer (CRC) expansion cohort from the phase I/II clinical trial of BRAF inhibitor dabrafenib (GSK2118436) plus MEK inhibitor trametinib (GSK1120212)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.3528-3528

2012

Volltextzugriff (PDF)

Modeling the risk of secondary lung malignancy in patients treated with breast radiation therapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1085-1085

2011

Volltextzugriff (PDF)

Can the well-credentialed neuroblastoma tumor antigen GD2 be exploited for T-cell-based immunotherapy of pediatric sarcomas?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9531-9531

2011

Volltextzugriff (PDF)

Global clinical experience with adjuvant oxaliplatin/5-fluorouracil (5-FU)-based chemotherapy for colon cancer: ACCElox registry

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14078-e14078

2011

Volltextzugriff (PDF)

Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk

Journal of clinical oncology, 2011-05, Vol.29 (13), p.1722-1727

2011

Volltextzugriff (PDF)

Early prediction of pathological complete response (pCR) of rectal cancer after 1 week of preoperative radiochemotherapy (RCT) using positron emission computererized tomography (PET-CT) imaging

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.572-572

2011

Volltextzugriff (PDF)

Evaluation of CYP24A1 mRNA expression as a prognostic marker and predictor of calcitriol activity in lung adenocarcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10631-10631

2010

Volltextzugriff (PDF)

MicroRNAs as a potential prognostic factor in gastric cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10635-10635

2010

Volltextzugriff (PDF)

ANG1005: Results of a phase I study in patients with advanced solid tumors and brain metastases

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2556-2556

2010

Volltextzugriff (PDF)

The interaction between smoking status and disease stage on non-small cell lung cancer (NSCLC) survival

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18021-e18021

2010

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

PublikationsformReviews

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Oncology
(11)
Humans
(9)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Middle Aged
(6)
Male
(5)
Adult
(4)
Female
(4)
Tumors
(4)
Aged
(3)
Cancer Research
(3)
Case-Control Studies
(2)
Gynecology. Andrology. Obstetrics
(2)
Pneumology
(2)
Predictive Value Of Tests
(2)
Societies, Medical
(2)
Tumors Of The Respiratory System And Mediastinum
(2)
14-3-3 Proteins - Immunology
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(51)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(51)
Publisher or Other Site
(51)
IngentaConnect Journals
(20)
IngentaConnect
(20)
MEDLINE
(9)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-world associations among patient-physician sex concordance, treatment practices, and cancer outcomes

Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer

Real-world use of biologics and its association with outcomes in RAS wild-type (WT) left-sided metastatic colorectal cancer (mCRC) in Canada

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

The association between medical cannabis and prescription opioid medication use in patients with early-stage cancer: A population-based study

Real-world treatment patterns and clinical outcomes in early stage non-small cell lung cancer (eNSCLC) in Canada

The impact of population-based EGFR testing in metastatic non-small cell lung cancer in Alberta

Trends and disparities in the treatment of older adults with colon cancer

CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

Safety and feasibility of rhenium-186 nanoliposome ( 186 RNL) in recurrent glioma: The ReSPECT phase 1 trial

Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial

Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640

Radiographic patterns of progression in patients with EGFR-mutant NSCLC undergoing EGFR TKI therapy

First-in-human investigation of the oral first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640

Perioperative DD-MVAC as a safe and efficacious treatment for MIBC: Results of a retrospective community center study with clinical correlates of toxicity and response

BRAF V600 mutant colorectal cancer (CRC) expansion cohort from the phase I/II clinical trial of BRAF inhibitor dabrafenib (GSK2118436) plus MEK inhibitor trametinib (GSK1120212)

Modeling the risk of secondary lung malignancy in patients treated with breast radiation therapy

Can the well-credentialed neuroblastoma tumor antigen GD2 be exploited for T-cell-based immunotherapy of pediatric sarcomas?

Global clinical experience with adjuvant oxaliplatin/5-fluorouracil (5-FU)-based chemotherapy for colon cancer: ACCElox registry

Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk

Early prediction of pathological complete response (pCR) of rectal cancer after 1 week of preoperative radiochemotherapy (RCT) using positron emission computererized tomography (PET-CT) imaging

Evaluation of CYP24A1 mRNA expression as a prognostic marker and predictor of calcitriol activity in lung adenocarcinoma

MicroRNAs as a potential prognostic factor in gastric cancer

ANG1005: Results of a phase I study in patients with advanced solid tumors and brain metastases

The interaction between smoking status and disease stage on non-small cell lung cancer (NSCLC) survival

Aktive Filter

Suchergebnisse filtern